Clinical Trial Update: Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two formulations of megestrol acetate oral suspension for AIDS-related weight loss completed; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids Wasting Syndrome
• Anorexia
• Cachexia
• HIV Infections
• HIV Wasting Syndrome

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: HIV Infections, Cachexia | Phase 2 | Status: COMPLETED | Results posted: 2016-04-20